Simona Montilla

410 total citations
13 papers, 238 citations indexed

About

Simona Montilla is a scholar working on Economics and Econometrics, Pharmacology and Hepatology. According to data from OpenAlex, Simona Montilla has authored 13 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Economics and Econometrics, 3 papers in Pharmacology and 3 papers in Hepatology. Recurrent topics in Simona Montilla's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Pharmaceutical Economics and Policy (7 papers) and Hepatitis C virus research (3 papers). Simona Montilla is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Pharmaceutical Economics and Policy (7 papers) and Hepatitis C virus research (3 papers). Simona Montilla collaborates with scholars based in Italy, Romania and United Kingdom. Simona Montilla's co-authors include Luca Pani, Franco Mazzei, Roberto Pilloton, Francesco Botrè, Claudio Botrè, Pietro Folino-Gallo, Nello Martini, Pierluigi Russo, Americo Cicchetti and P.D. Siviero and has published in prestigious journals such as Journal of Electroanalytical Chemistry, Liver International and Value in Health.

In The Last Decade

Simona Montilla

13 papers receiving 229 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simona Montilla Italy 7 79 59 46 36 34 13 238
Yuting Wang China 12 10 0.1× 30 0.5× 63 1.4× 51 1.4× 17 0.5× 39 315
Xianghui Wang China 10 3 0.0× 30 0.5× 74 1.6× 15 0.4× 19 0.6× 22 480
Rositsa Koleva‐Kolarova United Kingdom 10 67 0.8× 5 0.1× 32 0.7× 8 0.2× 6 0.2× 27 259
Junping Guo China 10 8 0.1× 16 0.3× 128 2.8× 11 0.3× 3 0.1× 40 341
Li Tao China 7 18 0.2× 35 0.6× 135 2.9× 4 0.1× 18 397
Michael Erbach Germany 9 7 0.1× 12 0.2× 68 1.5× 168 4.7× 2 0.1× 15 245
Jiang Ji China 9 4 0.1× 9 0.2× 56 1.2× 23 0.6× 2 0.1× 24 278
Nejc Piko Slovenia 8 5 0.1× 43 0.7× 41 0.9× 34 0.9× 30 273
Ayumi Ito Japan 10 1 0.0× 33 0.6× 69 1.5× 16 0.4× 25 0.7× 45 286

Countries citing papers authored by Simona Montilla

Since Specialization
Citations

This map shows the geographic impact of Simona Montilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simona Montilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simona Montilla more than expected).

Fields of papers citing papers by Simona Montilla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simona Montilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simona Montilla. The network helps show where Simona Montilla may publish in the future.

Co-authorship network of co-authors of Simona Montilla

This figure shows the co-authorship network connecting the top 25 collaborators of Simona Montilla. A scholar is included among the top collaborators of Simona Montilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simona Montilla. Simona Montilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gallo, V., et al.. (2022). The timelines for the price and reimbursement authorization in Italy 2018–2020. Frontiers in Medicine. 9. 1055359–1055359. 2 indexed citations
2.
Mennini, Francesco Saverio, Andrea Marcellusi, Sarah Robbins Scott, et al.. (2021). The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries. Liver International. 41(5). 934–948. 18 indexed citations
3.
Jommi, Claudio, et al.. (2018). Accesso precoce al mercato: dalle approvazioni condizionate di EMA agli accordi negoziali particolari di AIFA. Global & Regional Health Technology Assessment. 5(1). 2 indexed citations
4.
Jommi, Claudio, et al.. (2018). Accesso precoce al mercato: dalle approvazioni condizionate di EMA agli accordi negoziali particolari di AIFA. Global & Regional Health Technology Assessment. 2018. 491208780–491208780. 5 indexed citations
5.
Martini, Silvia, Maria Francesca Donato, Chiara Mazzarelli, et al.. (2017). The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real‐life experience. Liver International. 38(4). 733–741. 8 indexed citations
6.
Carrai, Paola, Maria Cristina Morelli, Antonietta Romano, et al.. (2017). The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes. Transplant International. 30(12). 1253–1265. 2 indexed citations
7.
Montilla, Simona, Entela Xoxi, Pierluigi Russo, Americo Cicchetti, & Luca Pani. (2015). MONITORING REGISTRIES AT ITALIAN MEDICINES AGENCY: FOSTERING ACCESS, GUARANTEEING SUSTAINABILITY. International Journal of Technology Assessment in Health Care. 31(4). 210–213. 36 indexed citations
8.
Montilla, Simona, Giulio Marchesini, Maria Paola Trotta, et al.. (2014). Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: Data from the Italian AIFA Anti-diabetics Monitoring Registry. Nutrition Metabolism and Cardiovascular Diseases. 24(12). 1346–1353. 38 indexed citations
9.
Pasternack, Iris, Jenni M. Vuola, Marc Van de Casteele, et al.. (2014). PILOTING INTERNATIONAL PRODUCTION OF RAPID RELATIVE EFFECTIVENESS ASSESSMENTS OF PHARMACEUTICALS. International Journal of Technology Assessment in Health Care. 30(5). 521–529. 3 indexed citations
10.
Bernardini, Claudia, et al.. (2014). Managed entry agreements. Orphanet Journal of Rare Diseases. 9(Suppl 1). O27–O27. 9 indexed citations
11.
12.
Folino-Gallo, Pietro, et al.. (2008). Pricing and reimbursement of pharmaceuticals in Italy. The European Journal of Health Economics. 9(3). 305–310. 38 indexed citations
13.
Mazzei, Franco, et al.. (2004). Alkaline phosphatase inhibition based electrochemical sensors for the detection of pesticides. Journal of Electroanalytical Chemistry. 574(1). 95–100. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuting Wang Breakdown of academic impact, for papers by Xianghui Wang Breakdown of academic impact, for papers by Rositsa Koleva‐Kolarova Breakdown of academic impact, for papers by Junping Guo Breakdown of academic impact, for papers by Li Tao Breakdown of academic impact, for papers by Michael Erbach Breakdown of academic impact, for papers by Jiang Ji Breakdown of academic impact, for papers by Nejc Piko Breakdown of academic impact, for papers by Ayumi Ito
Rankless by CCL
2026